PLEASE SHOW ALL WORK!

THANK YOU!

Exercise 16-10 Your answer is partially correct. Try again. On November 1, 2020, Sheridan Company adopted a stock-option plan that granted options to key executives to purchase 31,800 shares of the company's $9 par value common stock. The options were granted on January 2, 2021, and were exercisable 2 years after the date of grant if the grantee was still an employee of the company. The options expired 6 years from date of grant. The option price was set at $40, and the fair value option-pricing model determines the total compensation expense to be $477,000. All of the options were exercised during the year 2023: 21,200 on January 3 when the market price was $68, and 10,600 on May 1 when the market price was $77 a share. Prepare journal entries relating to the stock option plan for the years 2021, 2022, and 2023. Assume that the employee performs services equally in 2022 and 2023. (Credit account titles are automatically indented when amount is entered. Do not indent manually. If no entry is required, select "No Entry" for the account titles and enter 0 for the amounts. Round intermediate calculations to 5 decimal places, e.g. 1.24687 and final answers to 0 decimal places, e.g. 5,125.) Date Account Titles and Explanation Debit Credit || Jan. 2, 2021 No Entry No Entry Dec. 31, 2021 pensation Expense 238,500) Paid-in Capital-Stock O 238,500 Il Dec. 31, 2022 Tcompensation Expense 238,500 Paid-in Capital-Stock O 238,500 Jan. 3, 2023 Dcash Cash 848,000 TPaid-in Capital-Stock Optic 319,590 Common Stock 190,800 Paid-in Capital in Exces 976,790 May 1, 2023 424,000 TPaid-in Capital-Stock Optic 157,410 Common Stock 95,400 . Paid-in Capital in Exces 486,0